Echocardiogram
RadiationEvaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM
Other names: ALB / cr ratio, Fundus examination, ECG, Doppler on lower limbs, Nerve conduction, Echo
NCT Number: NCT06073756
Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM
Trial opening soon.
Get Notified18 year–75 year
All sexes
Observational
Vascular complications of DM result from various disorders including metabolic, cellular, and blood disturbances. Excessive production of pro-inflammatory adipokines from adipose tissue, resulting in low-grade chronic inflammation, causing insulin resistance (IR) and type 2 DM [3]. Hematological changes affecting the red blood cells (RBCs), white blood cells (WBCs), platelet function, and the coagulation factors are detected to be associated with DM . It is important to add that, high WBC count, one of the chief components of inflammatory process, sharing to atheroscle-rosis development and cardiovascular diseases (CVD) . Lately, the neutrophil-to-lymphocyte (N/L) and the platelet-to-lymphocyte (P/L) ratios, were offered as markers of inflammation in cardiac diseases, neoplasms and diabetes-related complications . Moreover, high leucocyte counts have been used as diagnostic and prognostic markers in vascular complication of diabetes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM
Other names: ALB / cr ratio, Fundus examination, ECG, Doppler on lower limbs, Nerve conduction, Echo
Time frame: Basline
Measurement of Neutrophils to lymhocyte ratio and platelets to lymhocyte ratio in patients with type 2 DM
Time frame: Basline
Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM
Contact information is provided by the study sponsor or research team.
Ammar Ashraf Fathy
CONTACT
Salah abdelazem Argoon
CONTACT
Assiut University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07658807
Arterial Occlusive Diseases, Arteriosclerosis
Beijing, China
View Trial DetailsNCT06485362
Cardiovascular Diseases, Diabetes Complications
Seville, Spain
View Trial DetailsNCT05282680
Autoimmune Diseases, Brain Diseases
Shatin, Hong Kong
View Trial DetailsNCT06035536
Cardiovascular Diseases, Chronic Foot Ulcer
Los Angeles, California, United States
View Trial Details